Here, we combined structural elements found in inhibitors of three kinases—GSK-3β, IKK-β, and ROCK-1—to develop multifunctional ligands targeting processes involved in the progression of Alzheimer’s disease. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.